Skip to main content

Accelrys to Acquire SciTegic for $21.5M in Cash and Stock

NEW YORK, Sept. 14 (GenomeWeb News) - Accelrys plans to acquire SciTegic, a provider of workflow software for research, for about $21.5 million in cash and stock, the company said today.


San Diego-based SciTegic will become a wholly-owned subsidiary of Accelrys, which plans to incorporate SciTegic's Pipeline Pilot software into its portfolio.


Shareholders of SciTegic will receive $12.25 million of cash and approximately one million shares of Accelrys common stock in exchange for their SciTegic shares at closing, and about 300,000 additional Accelrys shares over the next two years. The acquisition is subject to approval by SciTegic shareholders and is expected to close this month.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.